1,967
Views
0
CrossRef citations to date
0
Altmetric
Oncology

RNA-seq analysis identifies transcriptomic profiles associated with anal cancer recurrence among people living with HIV

, , , , , , , , , & show all
Article: 2199366 | Received 11 Aug 2022, Accepted 31 Mar 2023, Published online: 13 May 2023

References

  • Salati SA, Kadi A. A. Anal cancer – a review. Int J Health Sci. 2012;6(2):1–10.
  • American Cancer Society. Cancer Facts & Figures 2020. Atlanta, Ga: American Cancer Society; 2020.
  • American Cancer Society. Cancer Facts & Figures 2023. Atlanta, Ga: American Cancer Society; 2023.
  • Zhang ER, Pfeiffer RM, Austin A, et al. Impact of HIV on anal squamous cell carcinoma rates in the United States, 2001–2015. J Natl Cancer Inst. 2022;114(9):1246–1252.
  • Chaturvedi AK, Madeleine MM, Biggar RJ, et al. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst. 2009;101(16):1120–1130.
  • Shiels MS, Cole SR, Kirk GD, et al. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009;52(5):611–622.
  • Yanik EL, Katki HA, Engels EA. Cancer risk among the HIV-infected elderly in the United States. AIDS. 2016;30(10):1663–1668.
  • Robbins HA, Pfeiffer RM, Shiels MS, et al. Excess cancers among HIV-infected people in the United States. J Natl Cancer Inst. 2015;107(4):dju503.
  • Colón-López V, Shiels MS, Machin M, et al. Anal cancer risk among people with HIV infection in the United States. J Clin Oncol. 2018;36(1):68–75.
  • Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR anal cancer trial working party. UK Co-ordinating committee on cancer research. Lancet. 1996;348​(9034):​1049–1054.
  • Northover J, Glynne-Jones R, Sebag-Montefiore D, et al. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR anal cancer trial (ACT I). Br J Cancer. 2010;102(7):1123–1128.
  • Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the european organization for research and treatment of cancer radiotherapy and gastrointestinal cooperative groups. J Clin Oncol. 1997;15(5):2040–2049.
  • Deshmukh AA, Suk R, Shiels MS, Sonawane K, et al. Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001–2015. J Natl Cancer Inst. 2019;112(8):829–838.
  • Faynsod M, Vargas HI, Tolmos J, et al. Patterns of recurrence in anal canal carcinoma. Arch Surg. 2000;135(9):1090–1093. discussion 1094–1095.
  • Ghosn M, Kourie HR, Abdayem P, et al. Anal cancer treatment: current status and future perspectives. World J Gastroenterol. 2015;21(8):2294–2302.
  • Uronis HE, Bendell JC. Anal cancer: an overview. Oncologist. 2007;12(5):524–534.
  • Yanik EL, Kaunitz GJ, Cottrell TR, et al. Association of HIV status with local immune response to anal squamous cell carcinoma: implications for immunotherapy. JAMA Oncol. 2017;3(7):974–978.
  • Smaglo BG, Tesfaye A, Halfdanarson TR, et al. Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas. Oncotarget. 2015;6(41):43594–43604.
  • Shin S, Park HC, Kim MS, et al. Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus. Hum Pathol. 2018;80:1–10.
  • Morris V, Rao X, Pickering C, et al. Comprehensive genomic profiling of metastatic squamous cell carcinoma of the anal canal. Mol Cancer Res. 2017;15(11):1542–1550.
  • Koncar RF, Feldman R, Bahassi EM, et al. Comparative molecular profiling of HPV-induced squamous cell carcinomas. Cancer Med. 2017;6(7):1673–1685.
  • Chung JH, Sanford E, Johnson A, et al. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes. Ann Oncol. 2016;27(7):1336–1341.
  • Mouw KW, Cleary JM, Reardon B, et al. Genomic evolution after chemoradiotherapy in anal squamous cell carcinoma. Clin Cancer Res. 2017;23(12):3214–3222.
  • Hong M, Tao S, Zhang L, et al. RNA sequencing: new technologies and applications in cancer research. J Hematol Oncol. 2020;13(1):166.
  • Xi X, Li T, Huang Y, et al. RNA biomarkers: frontier of precision medicine for cancer. Noncoding RNA. 2017;3(1):9.
  • Krueger F. Trim Galore! [http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/].
  • Maroney KJ, Pinski AN, Marzi A, et al. Transcriptional analysis of infection with early or late isolates from the 2013-2016 west africa ebola virus epidemic does not suggest attenuated pathogenicity as a result of genetic variation. Front Microbiol. 2021;12:714817.
  • R Core Team. R: a language and environment for statistical computing. 2017. https://www.R-project.org/
  • Haw RA, Croft D, Yung CK, et al. The reactome BioMart. Database. 2011;2011:bar031.
  • Kim D, Paggi JM, Park C, et al. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907–915.
  • Lansdon LA, Cadieux-Dion M, Yoo B, et al. Factors affecting migration to GRCh38 in laboratories performing clinical Next-Generation sequencing. J Mol Diagn. 2021;23(5):651–657.
  • Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–140.
  • Powers RK, Goodspeed A, Pielke-Lombardo H, et al. GSEA-inContext: identifying novel and common patterns in expression experiments. Bioinformatics. 2018;34(13):i555–i564.
  • Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.
  • AJCC Cancer Staging Manual. 8th ed. In. Edited by cancer AJCo. New York City: springer; 2017. pp. 275.
  • Blighe K, Rana S, Lewis M. 2022. EnhancedVolcano: publication-ready volcano plots with enhanced colouring and labeling. R package version 1.16.0, https://github.com/kevinblighe/EnhancedVolcano.
  • Demchak B, Otasek D, Pico AR, et al. The cytoscape automation app article collection. F1000Res. 2018;7:800.
  • Land WG, Agostinis P, Gasser S, et al. DAMP-Induced allograft and tumor rejection: the circle is closing. Am J Transplant. 2016;16(12):3322–3337.
  • Lin R, Fogarty CE, Ma B, et al. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. BMC Genomics. 2021;22(1):576.
  • Qi S, Su L, Li J, et al. Arf6-driven endocytic recycling of CD147 determines HCC malignant phenotypes. J Exp Clin Cancer Res. 2019;38(1):471.
  • Zhao DD, Zhao X, Li WT. Identification of differentially expressed metastatic genes and their signatures to predict the overall survival of uveal melanoma patients by bioinformatics analysis. Int J Ophthalmol. 2020;13(7):1046–1053.
  • Ehrchen JM, Sunderkotter C, Foell D, et al. The endogenous toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol. 2009;86(3):557–566.
  • Gebhardt C, Nemeth J, Angel P, et al. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol. 2006;72(11):1622–1631.
  • Ghavami S, Chitayat S, Hashemi M, et al. S100A8/A9: a janus-faced molecule in cancer therapy and tumorgenesis. Eur J Pharmacol. 2009;625(1-3):73–83.
  • Srikrishna G. S100A8 and S100A9: new insights into their roles in malignancy. J Innate Immun. 2012;4(1):31–40.
  • Dougall WC, Kurtulus S, Smyth MJ, et al. TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy. Immunol Rev. 2017;276(1):112–120.
  • Ye W, Luo C, Liu F, et al. CD96 correlates with immune infiltration and impacts patient prognosis: a pan-cancer analysis. Front Oncol. 2021;11:634617.
  • Nobuoka D, Yoshikawa T, Fujiwara T, et al. Peptide intra-tumor injection for cancer immunotherapy: enhancement of tumor cell antigenicity is a novel and attractive strategy. Hum Vaccin Immunother. 2013;9(6):1234–1236.
  • Mousa H, Yuan M, Zhang X, et al. MicroRNA-4316 inhibits gastric cancer proliferation and migration via directly targeting VEGF-A. Cancer Cell Int. 2020;20:62.
  • Wang F, Zu Y, Huang W, et al. LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316. Biochem Biophys Res Commun. 2018;504(1):171–176.
  • Wang N, Gu Y, Li L, et al. Circular RNA circMYO9B facilitates breast cancer cell proliferation and invasiveness via upregulating FOXP4 expression by sponging miR-4316. Arch Biochem Biophys. 2018;653:63–70.
  • Krawczyk P, Powrózek T, Olesiński T, et al. Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer. Int J Colorectal Dis. 2017;32(7):1057–1060.
  • Duan S, Luo X, Zeng H, et al. SNORA71B promotes breast cancer cells across blood-brain barrier by inducing epithelial-mesenchymal transition. Breast Cancer. 2020;27(6):1072–1081.
  • Schulten HJ, Bangash M, Karim S, et al. Comprehensive molecular biomarker identification in breast cancer brain metastases. J Transl Med. 2017;15(1):269.
  • Wu G, Hao C, Qi X, et al. LncRNA SNHG17 aggravated prostate cancer progression through regulating its homolog SNORA71B via a positive feedback loop. Cell Death Dis. 2020;11(5):393.
  • Wang F, Gu T, Chen Y, et al. Long non-coding RNA SOX21-AS1 modulates lung cancer progress upon microRNA miR-24-3p/PIM2 axis. Bioengineered. 2021;12(1):6724–6737.
  • Zhang X, Zhao X, Li Y, et al. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1. J Cell Physiol. 2019;234(10):17494–17504.
  • Li L, Meng D, Wang R. Long non-coding RNA SOX21-AS1 enhances the stemness of breast cancer cells via the hippo pathway. FEBS Open Bio. 2021;11(1):251–264.
  • Yang CM, Wang TH, Chen HC, et al. Aberrant DNA hypermethylation-silenced SOX21-AS1 gene expression and its clinical importance in oral cancer. Clin Epigenetics. 2016;8:129.
  • Eenjes E, Buscop-van Kempen M, Boerema-de Munck A, et al. SOX21 modulates SOX2-initiated differentiation of epithelial cells in the extrapulmonary airways. Elife. 2021;10:e57325.
  • Keysar SB, Le PN, Miller B, et al. Regulation of head and neck squamous cancer stem cells by PI3K and SOX2. J Natl Cancer Inst. 2017;109(1-12).
  • Katoh Y, Katoh M. Hedgehog signaling pathway and gastric cancer. Cancer Biol Ther. 2005;4(10):1050–1054.
  • Sigafoos AN, Paradise BD, Fernandez-Zapico ME. Hedgehog/GLI signaling pathway: transduction, regulation, and implications for disease. Cancers. 2021;13(14):3410.
  • Zaphiropoulos PG, Unden AB, Rahnama F, et al. PTCH2, a novel human patched gene, undergoing alternative splicing and up-regulated in basal cell carcinomas. Cancer Res. 1999;59(4):787–792.
  • Jeong D, Qomaladewi NP, Lee J, et al. The role of autophagy in skin fibroblasts, keratinocytes, melanocytes, and epidermal stem cells. J Invest Dermatol. 2020;140(9):1691–1697.